Header with NDRS and NHS ENGLAND logos. Decorative only.

ODN Report: National Overview

Reporting period: January 2025 to December 2025

Introduction and Definitions

Introduction

The Operational Delivery Network (ODN) reports are produced every 6 months by the National Disease Registration Service. It is a summary of activity reports and metrics available on CancerStats2. This report uses data from the CAS snapshot CAS2605 (and includes RTDS activity up to December 2025). Further details on each of the reports can be found on CancerStats2.

ODNs are a delivery network for radiotherapy services. They were established by the Adult External Beam Radiotherapy Services Service Specification in 2019. Each Network is tasked with providing radiotherapy system leadership and the delivery of NHS England’s vision and ambitions for the modernisation of radiotherapy service.

Quality Metrics Definitions

The report includes summaries of the Specialised Services Quality Dashboards (SSQDs) metrics, referred to in this report as “Quality dashboard”. The purpose of collecting SSQD data is to monitor the quality of these specialised services, helping providers and commissioning teams identify areas for improvement to ensure better patient outcomes and fair, safe care. CS2 provides the metrics by Trust of delivery, whereas this report focuses on the ODN regions, aggregating the trusts within it.

The definitions for the quality metrics are as follows.

RAD12A: Percentage of radical episodes (excluding non-melanoma skin cancer) where the difference between decision to treat date and treatment start date is greater than 31 days.
Description: The number of radical episodes (excluding non-melanoma skin cancer episodes) where the difference between the decision to treat date and the treatment start date is over 31 days, by the number of all radical episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-D48 excluding C44. Earliest clinically appropriate date is used where the episode is missing the decision to treat date. If both dates are available, the most recent (greatest) date from either the decision to treat date and earliest clinically appropriate date is used. External beam radiotherapy only.

RAD12B: Percentage of palliative episodes (excluding non-melanoma skin cancer) where the difference between the decision to treat date and treatment start date is greater than 31 days.
Description: The number of palliative episodes (excluding non-melanoma skin cancer episodes) where the difference between the decision to treat and the treatment start date is greater than 31 days, by the number of all palliative episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-D48 excluding C44. Earliest clinically appropriate date is used where the episode is missing the decision to treat date. If both dates are available, the most recent (greatest) date from either the decision to treat date and earliest clinically appropriate date is used. External beam radiotherapy only.

RAD13A: Percentage of radical lung episodes.
Description: The number of radical lung episodes, by the number of all lung episodes starting treatment in the reporting period.
Exceptions and assumptions: Includes all lung treatments, including SABR treatment. ICD10 codes C33-C34 only are included. External beam radiotherapy only.

RAD13B: Percentage of radical lung SABR episodes.
Description: The number of radical lung SABR episodes, divided by the number of all radical lung episodes starting treatment in the reporting period.
Exceptions and assumptions: Includes only SABR treatments. ICD10 codes C33-C34 only are included. External beam radiotherapy only.

RAD13C: Percentage of radical head and neck episodes.
Description: The number of radical head and neck episodes, divided by the number of all head and neck episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-C14 and C30-C32 only are included. External beam radiotherapy only.

RAD13D: Percentage of radical cervical episodes.
Description: The number of radical cervical episodes, divided by the number of all cervical episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 code C53 only is included. External beam radiotherapy only.

RAD14: Percentage of radical IMRT episodes.
Description: The number of radical IMRT episodes (including any SABR episodes), divided by the number of all radical episodes starting treatment in the reporting period.
Exceptions and assumptions: Numerator radical IMRT episodes: Excludes ICD10 codes C50, D05 and C44. Denominator all radical episodes: Excludes ICD10 code C44 only. External beam radiotherapy only.

RAD15A: Percentage of radical lung episodes treated using image guidance.
Description: The number of radical lung IMRT episodes (including any SABR episodes), divided by the number of all radical lung episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 code C33 - C34 only are included. External beam radiotherapy only. Radical episodes only.

RAD15B: Percentage of radical prostate episodes treated using image guidance.
Description: The number of radical prostate IMRT episodes (including any SABR episodes), divided by the number of all radical prostate episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 code C61 only is included. External beam radiotherapy only. Radical episodes only.

RAD15C: Percentage of radical head and neck episodes treated using image guidance.
Description: The number of radical head and neck IMRT episodes (including any SABR episodes), divided by the number of all radical head and neck episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-C14, C30-C32 only are included. External beam radiotherapy only. Radical episodes only.

RAD16: Average number of days between date of referral to a radiotherapy department to the treatment start date for Category 1 episodes.
Description: Sum of the number of days waited from decision to treat date to the treatment start date, divided by the number of episodes starting treatment in the reporting period.
Exceptions and assumptions: Earliest clinically appropriate date is used where episode is missing decision to treat date. If both dates are available, the most recent (greatest) date from either the decision to treat date and earliest clinically appropriate date is used. Radical episodes only. External beam radiotherapy only. Category 1 episodes only, including: Site (ICD10 codes) Head and Neck (C00-C06, C09-C14); Cervix, Vagina and Vulva (C51-C53); Anus (C21); Lung (C30-C36, C39); Oesophagus (C15)

RAD17: Percentage of breast episodes treated with less than or equal to 15 prescribed fractions.
Description: The number of breast episodes where the first prescription in the episode has 15 or less prescribed fractions, divided by the number of all breast episodes starting treatment in the reporting period.
Exceptions and assumptions: Excludes any episodes that are non-anatomically specific to the primary treatment region or metastasis. ICD10 codes C50 or D05 only are included. External beam radiotherapy only. Excludes electron beam treatment. Excludes palliative treatment.

RAD18: Percentage of metastatic bone episodes treated in a single attendance.
Description: The number of metastatic bone episodes treated in a single attendance, divided by the number of all metastatic bone episodes starting treatment in the reporting period.
Exceptions and assumptions: OPCS codes Z63-Z66, Z68-Z80 or Z84-Z87 only are included. Spinal cord compression with the expected OPCS codes of Z06 and Z07 are excluded. External beam radiotherapy only. Metastatic treatment region only included.

RAD19: Percentage of prostate episodes treated in 5, 19 or 20 attendances.
Description: Number of prostate episodes treated in 5, 19 or 20 attendances, divided by the number of prostate episodes treated in 5, 19, 20 or more attendances in the reporting period.
Exceptions and assumptions: ICD10 code C61 only included. External beam radiotherapy only. Excludes prophylactic and non-anatomically specific to the primary.

RAD20: Departmental average number of attendances per linac
Description: The total number of attendances divided by the total number of LINACs.
Exceptions and assumptions: Linac attendances only.

Events Dashboard Definitions

The events by provider (mapped up to ODN) are defined as a count of the number of events by provider where a patient was treated with radiotherapy. This count includes all patient activity associated with the provider, regardless of postcode (including overseas, null, invalid, etc.).

Episode count is a count of episodes starting in that month.

Attendance count is a count of appointments in that month.

Dose and Fractionation Definitions

Patients - the report includes all adult patients aged 18+.

RTDS activity is defined as a unique count of treatment episodes. A treatment episode is defined as a continuous period of care for radiotherapy including all preparation, planning and delivery of radiotherapy.

Dose and fractionation schedules have been compared to the guidance provided by the Royal College of Radiologists for radiotherapy treatments occurring during Covid 19, in addition to the standard radiotherapy dose fractionation guidance produced by the RCR. This guidance can be found on the RCR website.

Fractionation Categories:

Low Fractionation - less than 2Gy per fraction
Standard Fractionation - 2.0Gy - 2.49Gy per fraction
Mild-Moderate hypofractionation - 2.5Gy - 4.99Gy
Ultra-High hypofractionation - 5Gy or greater

Episode count is a count of episodes starting in that month.

About the NDRS

The National Disease Registration Service (NDRS) is part of NHS England (NHSE). Its purpose is to collect, curate, quality-assure and analyse on patients with cancer, congenital anomalies, and rare diseases. It provides robust surveillance to monitor and detect changes in health and disease in the population. NDRS is a vital resource that helps researchers, healthcare professionals and policy makers make decisions about NHS services and the treatments people receive.

The NDRS includes:

the National Cancer Registration and Analysis Service (NCRAS) and
the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS)

Healthcare professionals, researchers and policy makers use data to better understand population health and disease. The data is provided by patients and collected by the NHS as part of their care and support. The NDRS uses the data to help:

understand cancer, rare diseases, and congenital anomalies
improve diagnosis
plan NHS services
improve treatment
evaluate policy
improve genetic counselling

For queries relating to this document, please contact NDRS.datasets@nhs.net

Contacts and Resources at NDRS

The National Disease Registration Service (NDRS) are making every effort to support each NHS Trust in achieving the highest levels of data quality in their RTDS submission. To support this aim, the following resources are available:

Your NDRS Data Liaison Manager
Your Data Liaison Manager can provide extensive support to improve the quality of data submitted to the National Disease Registration Service. Please contact the RTDS Helpdesk: rtds.helpdesk@nhs.net for further details.

NDRS Data Hub and Website
A single point of access for all NDRS related information including cancer data collection, datasets, supporting tools, training materials and guidance documents: NDRS Data Hub: NDRS Data Hub.

CancerStats2
CancerStats2 is a secure reporting platform that is only available to organisations with a HSCN connection. The platform hosts a variety of RTDS dashboards, including the radiotherapy quality metrics dashboard, the dose and fractionation dashboard and regularly updated operational data. In addition to RTDS data, the platform features dashboards reporting for cancer incidence and mortality, molecular and genetics and systemic anti-cancer therapy. CancerStats2 platform enables key stakeholders to generate reports using NDRS data on a self-service basis. If you do not currently have access please contact the RTDS Helpdesk (rtds.helpdesk@nhs.net).

Data sources
The dashboards referenced here can be found on CancerStats2 below:

A HSCN connection and CancerStats2 account are required to access the dashboards.

Patient acknowledgement This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data is collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of NHS England.

Data Quality and Caveats

Providers

From January 2023, Salford Royal / Northern Care Alliance (trust code: RM3) is included with the Christie NHS Foundation Trust (trust code: RBV) data for all metrics in this report.

North Cumbria Integrated Care NHS Foundation Trust (RNN) merged with The Newcastle Upon Tyne NHS Foundation Trust (RTD) from April 2023. Data reported for RNN in the period January 2023 to June 2023 will therefore not represent a full six-month period, with all data reported under RTD from this point onwards.

The Royal Marsden NHS Foundation Trust have approximately 10% of their RTDS data missing between April 2023 and December 2023. The Royal Marsden typically account for 3-4% of all radiotherapy episodes in England.

Some providers have missing/low data in the period covered by this report due to the transition to V6.

Decision to treat date

The RTDS data item decision to treat date is used in the following metrics as a start point for time to treatment. In some instances, particularly in data for The Christie NHS Foundation Trust (RBV) and University Hospitals Coventry and Warwickshire (RKB), an incorrect decision to treat date is assigned to an episode because the patient has had a previous primary tumour. In the period January 2020 to June 2024 this affects less than 1% of tumours.

Using the report

The report contents can be found in the sidebar to the left of the main panel. Click on the headings to see the different sections available and navigate to that part of the report.

For more information about the data, hover over the data points on the graph.

To zoom in or out of the chart, click the plus or minus symbols at the top right-hand side or draw a box within the chart to zoom in on that area.

To move around the chart, click on the cross (‘Pan’) symbol at the top right-hand side. To reset the chart, click on the house symbol at the top right-hand side.

To focus on specific elements on the chart:

Click on the item in the legend to remove a line or set of data points
Double click on the item in the legend to select a line or set of data points.

In some cases, numbers for categories may be too small to be visible on the chart or via the tooltip, although they are included in the totals and on the legend. To see these, double click on the category in the legend as above.

Save the plot as a PNG file by clicking on the camera symbol at the top right-hand side.

Episodes

Episodes table

Radiotherapy Network	Total	01/2025	02/2025	03/2025	04/2025	05/2025	06/2025	07/2025	08/2025	09/2025	10/2025	11/2025	12/2025
Total	149,360	13,517	12,535	13,017	12,585	12,280	12,675	13,234	11,162	12,700	13,080	11,184	11,391
East Midlands	9,381	932	885	694	720	710	789	853	706	808	829	739	716
East of England	11,820	1,159	1,067	1,137	1,049	1,049	1,113	928	758	906	907	880	867
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	21,314	1,902	1,667	1,797	1,789	1,668	1,688	1,992	1,585	1,872	1,935	1,715	1,704
North Central and North East London	10,572	1,210	1,072	1,171	1,141	1,118	820	842	592	633	683	627	663
North East and Cumbria	10,552	891	856	945	859	815	930	967	835	872	892	796	894
Peninsula, Somerset, Avon and Gloucestershire	15,583	1,370	1,246	1,220	1,326	1,245	1,320	1,417	1,231	1,416	1,469	1,168	1,155
South East London, Kent and Medway	9,015	794	687	747	695	705	765	801	735	758	794	737	797
Thames Valley and Wessex	15,540	1,288	1,264	1,318	1,273	1,224	1,328	1,318	1,252	1,331	1,411	1,265	1,268
West London, Surrey and Sussex	15,022	1,253	1,217	1,319	1,196	1,173	1,223	1,367	1,131	1,343	1,356	1,238	1,206
West Midlands	14,703	1,265	1,172	1,248	1,139	1,195	1,297	1,299	1,097	1,367	1,302	1,112	1,210
West Yorks, South Yorks and Humber	15,858	1,453	1,402	1,421	1,398	1,378	1,402	1,450	1,240	1,394	1,502	907	911

Episodes - Quarterly

National and regional comparison of episode totals in current year to most recent pre-2020 year.

England:

Radiotherapy Network:

Episode Trends - current and pre 2020

Episodes in the current and pre 2020 year: England

Episodes in the current and pre 2020 year: Radiotherapy Network

Episodes in the last 5 years

Episodes in the last 5 years: England

Episodes in the last 5 years: Radiotherapy Network

Radical Episodes

Radical episodes table

Radiotherapy Network		01/2025	02/2025	03/2025	04/2025	05/2025	06/2025	07/2025	08/2025	09/2025	10/2025	11/2025	12/2025	Total
East Midlands	Radical Episodes	702	611	499	513	456	550	592	482	567	575	507	484	6,538
	All Episodes	932	885	694	720	710	789	853	706	808	829	739	716	9,381
	% Radical	75%	69%	72%	71%	64%	70%	69%	68%	70%	69%	69%	68%	70%
East of England	Radical Episodes	822	723	772	717	703	751	626	499	647	608	584	581	8,033
	All Episodes	1,159	1,067	1,137	1,049	1,049	1,113	928	758	906	907	880	867	11,820
	% Radical	71%	68%	68%	68%	67%	67%	67%	66%	71%	67%	66%	67%	68%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Radical Episodes	1,417	1,232	1,348	1,330	1,210	1,204	1,478	1,186	1,421	1,381	1,277	1,298	15,782
	All Episodes	1,902	1,667	1,797	1,789	1,668	1,688	1,992	1,585	1,872	1,935	1,715	1,704	21,314
	% Radical	75%	74%	75%	74%	73%	71%	74%	75%	76%	71%	74%	76%	74%
North Central and North East London	Radical Episodes	873	787	824	836	786	577	578	439	463	470	450	459	7,542
	All Episodes	1,210	1,072	1,171	1,141	1,118	820	842	592	633	683	627	663	10,572
	% Radical	72%	73%	70%	73%	70%	70%	69%	74%	73%	69%	72%	69%	71%
North East and Cumbria	Radical Episodes	622	586	677	577	550	676	673	578	616	615	589	630	7,389
	All Episodes	891	856	945	859	815	930	967	835	872	892	796	894	10,552
	% Radical	70%	68%	72%	67%	67%	73%	70%	69%	71%	69%	74%	70%	70%
Peninsula, Somerset, Avon and Gloucestershire	Radical Episodes	930	792	818	865	805	855	936	789	935	981	791	742	10,239
	All Episodes	1,370	1,246	1,220	1,326	1,245	1,320	1,417	1,231	1,416	1,469	1,168	1,155	15,583
	% Radical	68%	64%	67%	65%	65%	65%	66%	64%	66%	67%	68%	64%	66%
South East London, Kent and Medway	Radical Episodes	547	462	498	463	474	491	532	493	536	511	501	535	6,043
	All Episodes	794	687	747	695	705	765	801	735	758	794	737	797	9,015
	% Radical	69%	67%	67%	67%	67%	64%	66%	67%	71%	64%	68%	67%	67%
Thames Valley and Wessex	Radical Episodes	850	868	860	834	777	872	857	833	914	925	851	789	10,230
	All Episodes	1,288	1,264	1,318	1,273	1,224	1,328	1,318	1,252	1,331	1,411	1,265	1,268	15,540
	% Radical	66%	69%	65%	66%	63%	66%	65%	67%	69%	66%	67%	62%	66%
West London, Surrey and Sussex	Radical Episodes	889	841	934	828	785	864	953	799	942	950	884	827	10,496
	All Episodes	1,253	1,217	1,319	1,196	1,173	1,223	1,367	1,131	1,343	1,356	1,238	1,206	15,022
	% Radical	71%	69%	71%	69%	67%	71%	70%	71%	70%	70%	71%	69%	70%
West Midlands	Radical Episodes	914	816	890	789	806	902	921	783	932	873	764	829	10,219
	All Episodes	1,265	1,172	1,248	1,139	1,195	1,297	1,299	1,097	1,367	1,302	1,112	1,210	14,703
	% Radical	72%	70%	71%	69%	67%	70%	71%	71%	68%	67%	69%	69%	70%
West Yorks, South Yorks and Humber	Radical Episodes	1,091	1,019	1,061	1,060	989	1,069	1,080	888	1,034	1,139	689	661	11,780
	All Episodes	1,453	1,402	1,421	1,398	1,378	1,402	1,450	1,240	1,394	1,502	907	911	15,858
	% Radical	75%	73%	75%	76%	72%	76%	74%	72%	74%	76%	76%	73%	74%

Country		01/2025	02/2025	03/2025	04/2025	05/2025	06/2025	07/2025	08/2025	09/2025	10/2025	11/2025	12/2025	Total
England	Radical Episodes	9,657	8,737	9,181	8,812	8,341	8,811	9,226	7,769	9,007	9,028	7,887	7,835	104,291
	All Episodes	13,517	12,535	13,017	12,585	12,280	12,675	13,234	11,162	12,700	13,080	11,184	11,391	149,360
	% Radical	71%	70%	71%	70%	68%	70%	70%	70%	71%	69%	71%	69%	70%

Radical episodes - Quarters

Percentage of episodes that were radical by financial quarter, comparing current and pre 2020 years

England:

Radiotherapy Network:

Radical episode (%) trends - current and pre 2020

Radical episodes (%) in the current and pre 2020 year: England

Radical episodes (%) in the current and pre 2020 year: Radiotherapy Network

Radical episodes (%) in the last 5 years

Radical episodes (%) in the last 5 years: England

Radical episodes (%) in the last 5 years: Radiotherapy Network

Attendances

Attendances table

Radiotherapy Network	Total	01/2025	02/2025	03/2025	04/2025	05/2025	06/2025	07/2025	08/2025	09/2025	10/2025	11/2025	12/2025
Total	1,692,531	149,410	140,209	145,987	144,138	143,902	137,148	150,198	132,473	140,595	149,981	125,469	133,021
East Midlands	115,001	12,430	11,050	8,963	8,510	9,088	9,144	9,764	8,640	9,670	9,775	8,682	9,285
East of England	133,821	12,644	11,975	12,650	12,590	12,503	12,583	10,548	9,025	9,503	10,549	9,362	9,889
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	248,421	21,026	19,727	20,319	21,072	20,616	18,679	22,415	19,945	20,535	22,816	20,084	21,187
North Central and North East London	128,420	14,020	12,529	13,391	13,485	14,274	9,264	10,185	8,027	8,392	8,680	7,885	8,288
North East and Cumbria	112,419	9,396	9,034	9,562	9,300	8,799	9,423	10,368	9,262	9,524	9,929	8,436	9,386
Peninsula, Somerset, Avon and Gloucestershire	156,508	12,765	12,309	12,885	13,137	13,045	12,678	14,072	13,275	13,794	14,745	11,480	12,323
South East London, Kent and Medway	107,320	9,462	8,378	8,319	8,592	8,547	8,512	9,538	8,706	9,683	9,506	8,559	9,518
Thames Valley and Wessex	173,443	14,018	13,390	14,556	14,407	14,052	13,756	15,315	14,260	14,968	16,075	14,375	14,271
West London, Surrey and Sussex	165,297	13,623	13,071	14,622	13,647	13,133	13,302	14,915	13,046	14,113	14,826	13,283	13,716
West Midlands	175,913	14,526	13,941	15,160	14,084	14,386	14,688	16,431	13,951	15,334	16,108	13,135	14,169
West Yorks, South Yorks and Humber	175,968	15,500	14,805	15,560	15,314	15,459	15,119	16,647	14,336	15,079	16,972	10,188	10,989

Attendances - Quarterly

National and regional comparison of attendance totals in current year to most recent pre-2020 year.

England:

Radiotherapy Network:

Attendance Trends - current and pre 2020

Attendances in the current and pre 2020 year: England

Attendances in the current and pre 2020 year: Radiotherapy Network

Attendances in the last 5 years

Attendances in the last 5 years: England

Attendances in the last 5 years: Radiotherapy Network

Service Attendances - RAD20

Service Attendances

Machine Attendances (RAD20) - April 2024 to March 2025

Count by machine type

Attendance by machine type and Radiotherapy Network:

Percentage LINAC

Percentage of attendances LINAC
Radiotherapy Network	% LINAC
East Midlands	99%
East of England	97%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	99%
North Central and North East London	98%
North East and Cumbria	99%
Peninsula, Somerset, Avon and Gloucestershire	99%
South East London, Kent and Medway	98%
Thames Valley and Wessex	98%
West London, Surrey and Sussex	99%
West Midlands	98%
West Yorks, South Yorks and Humber	99%

RAD20 Over Time

Machine Attendances (RAD20) - LINAC Attendances

England:

Radiotherapy Network:

RAD20 National Annual Average

RAD20: Departmental average number of attendances per LINAC by financial year.

Financial years only: April-March

National Annual Average

Averages by Radiotherapy Network

Interpretation guidance: Higher is better
Reference Line: National annual average

Quality Dashboard

Specification

Specification for this version:

Unless otherwise stated

Proportion (%) = Sum(Numerator)/Sum(Denominator)

Working days=Sum(Numerator - Number of days waiting)/Sum(Denominator - number of episodes starting in that month) - (RAD16 only)

In the national overview RAD13A/B/C is the the total episodes for the whole country for each year. In the breakdown by radiotherapy network the figure shown is simply the sum of the numerator for the year for that network.

RAD19 is not included in this summary as its maximum end date is 2 months less than the metrics displayed here due to necessary followups.

Quality Dashboard Dates:

Annual Metric Dates
Time period	Start date	End date
Current Year	January 2025	December 2025
Previous Year	January 2024	December 2024

Quarterly Metric Dates
Quarter	Month
Curr Qtr	December 2025
	November 2025
	October 2025
Prev Qtr 1	September 2025
	August 2025
	July 2025
Prev Qtr 2	June 2025
	May 2025
	April 2025
Prev Qtr 3	March 2025
	February 2025
	January 2025

Quality Dashboard Overview

Quality Dashboard Overview: January 2025 to December 2025

Black line indicates the benchmark (BM) for each metric.

Yearly Metrics

National Overview: Yearly metrics

Previous year: January 2024 to December 2024, Current year: January 2025 to December 2025

Benchmarks: RAD13: 25 episodes higher is better, RAD15: 80% higher is better

Underlying Data - Overview

Quarterly Metrics - RAD12, RAD14, RAD17, RAD18
Metric		Prev Qtr 3	Prev Qtr 2	Prev Qtr 1	Curr Qtr
RAD12a	Proportion	33%	30%	30%	27%
	Numerator	8,183	7,079	6,863	5,876
	Denominator	24,597	23,219	23,158	22,127
RAD12b	Proportion	9%	9%	8%	8%
	Numerator	980	1,001	876	832
	Denominator	10,840	10,945	10,597	10,449
RAD14	Proportion	59%	60%	60%	60%
	Numerator	14,559	13,916	14,007	13,191
	Denominator	24,625	23,248	23,187	22,148
RAD17	Proportion	100%	100%	100%	100%
	Numerator	9,038	8,419	8,234	8,142
	Denominator	9,071	8,457	8,264	8,155
RAD18	Proportion	70%	68%	69%	68%
	Numerator	2,894	2,717	2,574	2,463
	Denominator	4,133	3,980	3,723	3,603

Quarterly Metric RAD16 - Average days waiting
Metric		Prev Qtr 3	Prev Qtr 2	Prev Qtr 1	Curr Qtr
RAD16	Working days	30	35	32	33
	Numerator	144,049	163,547	156,514	151,139
	Denominator	4,797	4,645	4,868	4,576

Annual Metric RAD15 - Proportion %
Metric		Previous Year	Current Year
RAD15a	Proportion	94%	95%
	Numerator	7,886	8,095
	Denominator	8,387	8,531
RAD15b	Proportion	97%	97%
	Numerator	23,482	23,222
	Denominator	24,274	23,923
RAD15c	Proportion	97%	97%
	Numerator	6,858	6,312
	Denominator	7,038	6,498

Annual Metric RAD13 - Total Numerator
Metric		Previous Year	Current Year
RAD13a	Numerator	8,387	8,531
RAD13b	Numerator	3,880	4,182
RAD13c	Numerator	7,038	6,498
RAD13d	Numerator	1,117	1,102

Quality Dashboard Network Overview

RAD12

RAD12 - Number of patients waiting longer than 31 days from decision to treat date to date of first treatment - Radical Treatment (A), Palliative Treatment (B), BM: 20% Lower better

RAD13

RAD13 - Number of episodes of radical treatment by tumour site - Lung - inc. SABR (A), Lung - SABR Only (B), Head & Neck (C), Cervix (D), BM: 25 Episodes

RAD14

RAD14: Proportion of all Radiotherapy Radical episodes receiving Inverse Planned IMRT (excluding breast). BM: 24% Higher better

RAD15

RAD15 - Proportion of radical patients treated using image guidance. Lung (A), Prostate (B), Head & Neck (C), BM: 80% Higher is better

RAD16

RAD16 - Mean waiting time (in days) from date of referral to radiotherapy department to the date of treatment commencing for Category 1 patients BM: 31 days lower is better

RAD17

Radiotherapy Network:

Percentage

Radical Episodes by Speciality (percentage) - Urology

England:

Radiotherapy Network:

Dose and Fractions

Unless otherwise stated the following data is for radical episodes only.

Breast

Dose fractionation schedules

Dose and Fractions - BREAST (January 2025 to December 2025)

Percentage of breast episodes by Radiotherapy Network and dose fractionation schedules.

Number of breast episodes by Radiotherapy Network and dose fractionation schedules.

Table

Table: number and percentage of breast episodes by Radiotherapy Network and dose fractionation schedules.

Radiotherapy Network		Total	26 Gy in 5 fractions	40 Gy in 15 fractions	48 Gy in 15 fractions	other
Total	Episodes	33,333	22,764	8,345	892	1,332
Total	Percentage	100%	68%	25%	3%	4%
East Midlands	Episodes	2,294	1,588	554	104	48
East Midlands	Percentage	7%	5%	2%	0%	0%
East of England	Episodes	2,743	1,814	537	222	170
East of England	Percentage	8%	5%	2%	1%	1%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Episodes	4,470	2,723	1,195	235	317
	Percentage	13%	8%	4%	1%	1%
North Central and North East London	Episodes	2,334	1,571	602	53	108
North Central and North East London	Percentage	7%	5%	2%	0%	0%
North East and Cumbria	Episodes	2,268	1,714	488	45	21
North East and Cumbria	Percentage	7%	5%	1%	0%	0%
Peninsula, Somerset, Avon and Gloucestershire	Episodes	3,437	2,400	835	2	200
Peninsula, Somerset, Avon and Gloucestershire	Percentage	10%	7%	3%	0%	1%
South East London, Kent and Medway	Episodes	2,103	1,483	581	2	37
South East London, Kent and Medway	Percentage	6%	4%	2%	0%	0%
Thames Valley and Wessex	Episodes	3,449	2,556	726	85	82
Thames Valley and Wessex	Percentage	10%	8%	2%	0%	0%
West London, Surrey and Sussex	Episodes	3,276	2,206	796	90	184
West London, Surrey and Sussex	Percentage	10%	7%	2%	0%	1%
West Midlands	Episodes	3,618	2,403	1,120	26	69
West Midlands	Percentage	11%	7%	3%	0%	0%
West Yorks, South Yorks and Humber	Episodes	3,341	2,306	911	28	96
West Yorks, South Yorks and Humber	Percentage	10%	7%	3%	0%	0%

RCR Schedules

Count

Number of breast episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Percentage

Percentage of breast episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Fraction Categories

Number of breast episodes by Radiotherapy Network, financial quarter and fractionation category

Dose fractionation schedules

Dose and Fractions - LUNG (January 2025 to December 2025)

Percentage of lung episodes by Radiotherapy Network and dose fractionation schedules.

Number of lung episodes by Radiotherapy Network and dose fractionation schedules.

Table

Table: number and percentage of lung episodes by Radiotherapy Network and dose fractionation schedules.

Radiotherapy Network		Total	30-60 Gy in 1-8 fractions	40-55 Gy in 15-20 fractions	45-66 Gy in 25-33 fractions	54 Gy in 36 fractions	other
Total	Episodes	8,439	3,618	2,009	1,170	19	1,623
Total	Percentage	100%	43%	24%	14%	0%	19%
East Midlands	Episodes	369	127	91	91	0	60
East Midlands	Percentage	4%	2%	1%	1%	0%	1%
East of England	Episodes	418	175	163	42	0	38
East of England	Percentage	5%	2%	2%	0%	0%	0%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Episodes	1,791	390	503	147	0	751
	Percentage	21%	5%	6%	2%	0%	9%
North Central and North East London	Episodes	512	227	65	109	0	111
North Central and North East London	Percentage	6%	3%	1%	1%	0%	1%
North East and Cumbria	Episodes	929	466	261	72	0	130
North East and Cumbria	Percentage	11%	6%	3%	1%	0%	2%
Peninsula, Somerset, Avon and Gloucestershire	Episodes	784	377	122	100	3	182
Peninsula, Somerset, Avon and Gloucestershire	Percentage	9%	4%	1%	1%	0%	2%
South East London, Kent and Medway	Episodes	424	158	113	89	0	64
South East London, Kent and Medway	Percentage	5%	2%	1%	1%	0%	1%
Thames Valley and Wessex	Episodes	816	402	125	188	1	100
Thames Valley and Wessex	Percentage	10%	5%	1%	2%	0%	1%
West London, Surrey and Sussex	Episodes	617	324	136	103	0	54
West London, Surrey and Sussex	Percentage	7%	4%	2%	1%	0%	1%
West Midlands	Episodes	603	296	183	77	0	47
West Midlands	Percentage	7%	4%	2%	1%	0%	1%
West Yorks, South Yorks and Humber	Episodes	1,176	676	247	152	15	86
West Yorks, South Yorks and Humber	Percentage	14%	8%	3%	2%	0%	1%

Radiotherapy Network:

Oesophagus

Dose fractionation schedules

Dose and Fractions - OESOPHAGUS (January 2025 to December 2025)

Percentage of oesophagus episodes by Radiotherapy Network and dose fractionation schedules.

Number of oesophagus episodes by Radiotherapy Network and dose fractionation schedules.

Table

Table: number and percentage of oesphagus episodes by Radiotherapy Network and dose fractionation schedules.

Radiotherapy Network		Total	40-55 Gy in 15-20 fractions	41.5-45 Gy in 23-28 fractions	50-66 Gy in 25-30 fractions	other
Total	Episodes	1,318	226	131	848	113
Total	Percentage	100%	17%	10%	64%	9%
East Midlands	Episodes	59	11	11	31	6
East Midlands	Percentage	4%	1%	1%	2%	0%
East of England	Episodes	98	26	15	45	12
East of England	Percentage	7%	2%	1%	3%	1%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Episodes	163	36	7	108	12
	Percentage	12%	3%	1%	8%	1%
North Central and North East London	Episodes	86	19	12	48	7
North Central and North East London	Percentage	7%	1%	1%	4%	1%
North East and Cumbria	Episodes	119	37	8	69	5
North East and Cumbria	Percentage	9%	3%	1%	5%	0%
Peninsula, Somerset, Avon and Gloucestershire	Episodes	114	6	11	85	12
Peninsula, Somerset, Avon and Gloucestershire	Percentage	9%	0%	1%	6%	1%
South East London, Kent and Medway	Episodes	90	14	6	61	9
South East London, Kent and Medway	Percentage	7%	1%	0%	5%	1%
Thames Valley and Wessex	Episodes	166	4	26	124	12
Thames Valley and Wessex	Percentage	13%	0%	2%	9%	1%
West London, Surrey and Sussex	Episodes	119	3	16	89	11
West London, Surrey and Sussex	Percentage	9%	0%	1%	7%	1%
West Midlands	Episodes	144	26	8	99	11
West Midlands	Percentage	11%	2%	1%	8%	1%
West Yorks, South Yorks and Humber	Episodes	160	44	11	89	16
West Yorks, South Yorks and Humber	Percentage	12%	3%	1%	7%	1%

RCR Schedules

Count

Number of oesophagus episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Percentage

Percentage of oesophagus episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Fraction Categories

Number of oesophagus episodes by Radiotherapy Network, financial quarter and fractionation category

Episodes and Attendances

Groupings are as below:

Brain and CNS: Brain (C71), Meninges (C70), Other CNS (C47, C72, D32-D33, D35, D42-D44), Pituitary (D352)

Gynae: Cervix (C53), Other gynae (C56-C57), Uterus (C54-C55), Vagina (C52), Vulva (C51)

Lower GI: Anal (C21), Other lower GI (C17-C18, C26), Rectal (C20), Rectosigmoid (C19)

Upper GI: HepatoPancreatoBiliary (C22-C25), Oesophagus (C15), Stomach (C16)

Urology: Bladder and ureter (C66-C67), Other urology (C63-C65, C68), Penis (C60), Prostate (C61), Testis (C62)

Quality Dashboard

The details of what is required for each submission can be found here:

Specialised Services Quality Dashboards

The metrics show what submissions are required for each indicator and whether the data is provider submitted or externally provided (for example from NDRS).

Dose and Fractions

Groupings are as below:

Breast (C50)

Head and neck (C00-C14, C30-C32)

Lung (C33, C34, excluding where Treatment Region = ‘O’ Prophylactic (to non primary site))

Prostate (C61; men only)

Oesophagus (C15)